H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab

Arzu Didem Yalcin, Atil Bisgin

Med Sci Monit 2012; 18(8): LET9-10

DOI: 10.12659/MSM.883249

Published: 2012-08-01



Keywords: Quality of Life, Humans, Asthma - drug therapy, Antibodies, Monoclonal, Humanized - therapeutic use, Antibodies, Anti-Idiotypic - therapeutic use, Anti-Asthmatic Agents - therapeutic use, Solubility, TNF-Related Apoptosis-Inducing Ligand - blood



Back